Press

October, 2019 , The Medicine Maker

Process Development 101: How Not to Burn Down Your Factory

Our Technical Director, Dr Jonathan Moseley, offers tips on how to manufacture your API in the right quantity, at the right cost, and in the right time frame - and not burn your factory down in the process!

By: Jonathan Moseley

September, 2019 , Chemistry Today

Panel Discussion on Custom Synthesis & Contract Manufacturing

Our Chief Operating Officer, Dr Simon Tyler participated in the latest Chemistry Today panel discussion on custom synthesis and manufacturing

September, 2019 , CHEManager International

The pharma CDMO challenge

Our Business Development Manager, Dr Joao Madeira do O recently spoke to CHEManager International to discuss the current market for process research and development CROs like CatSci.

September, 2019 , Chemicals Knowledge Hub

The growth of green chemistry

Our Senior Scientist, Dr Joe Renny recently spoke to Chemicals Knowledge Hub to discuss the importance of exploiting green chemistry to produce perfect for purpose process chemistry solutions.

May, 2019 , C&EN

British contract research firms fight to find science talent

In C&EN, our COO Dr Simon Tyler discusses the importance of welcoming graduate chemists into our company and how we are dedicated to growing our team with bright, talented minds.

February, 2019 , The Medicine Maker

Phasing Out Inefficiency

How can you ensure success when working with a CRO, such as CatSci, for process research and development? Hear from our COO, Dr Simon Tyler, in The Medicine Maker.

January, 2019 , Pharmaceutical Technology

Updating Manufacturing Processes to Improve Sustainability

Earlier this year, CatSci’s Dr. Jonathan Moseley spoke with Pharmaceutical Technology to discuss what makes our novel biocatalytic manufacturing process unique.

October, 2018 , CHEManager

How CDMOs tackle the current market developments

CatSci’s Dr Ross Burn joins several other top industry experts to offer insight into what current market developments are most challenging for Pharma CDMOs and how they can tackle them.

September, 2018 , Chemical Week

Fine chemicals: Pharmaceutical industry outlook is optimistic

Our CEO Dr Ross Burn talks to Michael Ravenscroft about the current trends in CRO outsourcing for the pharmaceutical market.

August, 2018 , Chemistry Today

Outsourcing: optimising an asset and an organisation

In 2018, our CEO Ross Burn took part in Chemistry Today’s Panel Discussion on Custom Synthesis and Contract Manufacturing.

August, 2018 , C&EN

How former drug company labs are becoming contract research firms

Learn about our growth as a contract research organisation for the Pharma industry in this article, featuring our COO, Dr Simon Tyler.

July, 2018 , Chemicals Knowledge Hub

Optimizing Your Asset, Minimizing the Risk

Dr Ross Burn, CEO and Dr Simon Tyler, COO at CatSci explain how process optimization can play an integral part in optimizing yield while reducing time and costs.

March, 2018 , Chemistry World

Biosensors, wearables and virtual tech

In a world that is racing ahead with new technologies, has the drug development process distanced itself from the patients it ultimately provides for? Hear more from our Chief Executive Officer, Dr. Ross Burn.